"1.000 m2 kapalı alanda, toplam 16 katta, 87 hasta yatağı, 10 erişkin yoğun bakım yatağı, 5 yenidoğan yoğun bakım yatağı,15 bebek odası yatağı, 6 ameliyathane bulunmaktadır. Medikal Onkoloji, Radyasyon Onkolojisi, Gammaknife, Pet MR, Nükleer Tıp, Endoskopi ve Bronkoskopi, Radyoloji ünitesi, Genetik Hastalıklar Tanı Merkezi, Patoloji Laboratuvarı, Doku Tipleme ve İmmünoloji Laboratuvarı, Biyokimya Laboratuvarı ve Mikrobiyoloji Laboratuvarları ile hastalarının hizmetindedir."

During the past decade, TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology" are "Atrial Fibrillation" (1 trials), "Mitral Valve Stenosis" (1 trials), "NMO Spectrum Disorder (NMOSD)" (1 trials), "Neuromyelitis Optica (NMO)" (1 trials) and "Neuromyelitis Optica Spectrum Disorder" (1 trials). Many other conditions were trialed in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology" in a lesser frequency.

Most popular intervention types in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Satralizumab" (1 trials), "azathioprine (AZA)" (1 trials), "mycophenolate mofetil (MMF)" (1 trials) and "oral corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TC.Istanbul Bilim University, Florence Nightingale Hospital, Division of Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".